Introduction to the metabolic syndrome

被引：46

作者：

Alberti, G ^{[1
]}

机构：

[1] St Marys Hosp, Dept Endocrinol & Metab Med, London W2 1NY, England

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2005年 / 7卷 / 0D期

关键词：

D O I：

10.1093/eurheartj/sui021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：D3 / D5

页数：3

共 17 条

[1]

Avogaro P, 1965, DIABETOLOGIA, V1, P137

[2]

Balkau B, 1999, DIABETIC MED, V16, P442

[3] HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study [J].

Bonora, E ;

Formentini, G ;

Calcaterra, F ;

Lombardi, S ;

Marini, F ;

Zenari, L ;

Saggiani, F ;

Poli, M ;

Perbellini, S ;

Raffaelli, A ;

Cacciatori, V ;

Santi, L ;

Targher, G ;

Bonadonna, R ;

Muggeo, M .

DIABETES CARE, 2002, 25 (07) :1135-1141

[4] No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial [J].

Carr, A ;

Workman, C ;

Carey, D ;

Rogers, G ;

Martin, A ;

Baker, D ;

Wand, H ;

Law, M ;

Samaras, K ;

Emery, S ;

Cooper, DA .

LANCET, 2004, 363 (9407) :429-438

[5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[6] The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study [J].

Dunstan, DW ;

Zimmet, PZ ;

Welborn, TA ;

de Courten, MP ;

Cameron, AJ ;

Sicree, RA ;

Dwyer, T ;

Colagiuri, S ;

Jolley, D ;

Knuiman, M ;

Atkins, R ;

Shaw, JE .

DIABETES CARE, 2002, 25 (05) :829-834

[7]

Gavin JR, 1997, DIABETES CARE, V20, P1183

[8] Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].

Grundy, SM ;

Brewer, HB ;

Cleeman, JI ;

Smith, SC ;

Lenfant, C .

CIRCULATION, 2004, 109 (03) :433-438

[9] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X) [J].

HAFFNER, SM ;

VALDEZ, RA ;

HAZUDA, HP ;

MITCHELL, BD ;

MORALES, PA ;

STERN, MP .

DIABETES, 1992, 41 (06) :715-722

[10] The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives [J].

Hills, SA ;

Balkau, B ;

Coppack, SW ;

Dekker, JM ;

Mari, A ;

Natali, A ;

Walker, M ;

Ferrannini, E .

DIABETOLOGIA, 2004, 47 (03) :566-570

← 1 2 →